Recent studies have indicated a role for caveolin in regulating cholesterol-dependent signaling events. In the present study we have analyzed the role of caveolins in intracellular cholesterol cycling using a dominant negative caveolin mutant. The mutant caveolin protein, cav-3DGV, specifically associates with the membrane surrounding large lipid droplets. These structures contain neutral lipids, and are accessed by caveolin 1–3 upon overexpression. Fluorescence, electron, and video microscopy observations are consistent with formation of the membrane-enclosed lipid rich structures by maturation of subdomains of the ER. The caveolin mutant causes the intracellular accumulation of free cholesterol (FC) in late endosomes, a decrease in surface cholesterol and a decrease in cholesterol efflux and synthesis. The amphiphile U18666A acts synergistically with cavDGV to increase intracellular accumulation of FC. Incubation of cells with oleic acid induces a significant accumulation of full-length caveolins in the enlarged lipid droplets. We conclude that caveolin can associate with the membrane surrounding lipid droplets and is a key component involved in intracellular cholesterol balance and lipid transport in fibroblasts.
Skip Nav Destination
Article navigation
5 March 2001
Article Contents
Article|
March 05 2001
A Caveolin Dominant Negative Mutant Associates with Lipid Bodies and Induces Intracellular Cholesterol Imbalance
Albert Pol,
Albert Pol
aInstitute for Molecular Bioscience, Centre for Microscopy and Microanalysis and Department of Physiology and Pharmacology, University of Queensland, Queensland 4072, Australia
Search for other works by this author on:
Robert Luetterforst,
Robert Luetterforst
aInstitute for Molecular Bioscience, Centre for Microscopy and Microanalysis and Department of Physiology and Pharmacology, University of Queensland, Queensland 4072, Australia
Search for other works by this author on:
Margaret Lindsay,
Margaret Lindsay
aInstitute for Molecular Bioscience, Centre for Microscopy and Microanalysis and Department of Physiology and Pharmacology, University of Queensland, Queensland 4072, Australia
Search for other works by this author on:
Sanna Heino,
Sanna Heino
bDepartment of Biochemistry, National Public Health Institute, 00300 Helsinki, Finland
Search for other works by this author on:
Elina Ikonen,
Elina Ikonen
bDepartment of Biochemistry, National Public Health Institute, 00300 Helsinki, Finland
Search for other works by this author on:
Robert G. Parton
Robert G. Parton
aInstitute for Molecular Bioscience, Centre for Microscopy and Microanalysis and Department of Physiology and Pharmacology, University of Queensland, Queensland 4072, Australia
Search for other works by this author on:
Albert Pol
aInstitute for Molecular Bioscience, Centre for Microscopy and Microanalysis and Department of Physiology and Pharmacology, University of Queensland, Queensland 4072, Australia
Robert Luetterforst
aInstitute for Molecular Bioscience, Centre for Microscopy and Microanalysis and Department of Physiology and Pharmacology, University of Queensland, Queensland 4072, Australia
Margaret Lindsay
aInstitute for Molecular Bioscience, Centre for Microscopy and Microanalysis and Department of Physiology and Pharmacology, University of Queensland, Queensland 4072, Australia
Sanna Heino
bDepartment of Biochemistry, National Public Health Institute, 00300 Helsinki, Finland
Elina Ikonen
bDepartment of Biochemistry, National Public Health Institute, 00300 Helsinki, Finland
Robert G. Parton
aInstitute for Molecular Bioscience, Centre for Microscopy and Microanalysis and Department of Physiology and Pharmacology, University of Queensland, Queensland 4072, Australia
The online version of this article contains supplemental material.
Abbreviations used in this paper: BFA, brefeldin A; CDV, cavDGV enriched vesicles; FC, free cholesterol; GFP, green fluorescent protein; NPC, Niemann-Pick disease C; PDI, phosphodisulphide isomerase; PM, plasma membrane; SCAP, SREBP-cleavage activating protein; SREBP, sterol-regulatory element-binding protein; YFP, yellow fluorescent protein.
Received:
October 02 2000
Revision Requested:
December 18 2000
Accepted:
January 23 2001
Online ISSN: 1540-8140
Print ISSN: 0021-9525
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Cell Biol (2001) 152 (5): 1057–1070.
Article history
Received:
October 02 2000
Revision Requested:
December 18 2000
Accepted:
January 23 2001
Citation
Albert Pol, Robert Luetterforst, Margaret Lindsay, Sanna Heino, Elina Ikonen, Robert G. Parton; A Caveolin Dominant Negative Mutant Associates with Lipid Bodies and Induces Intracellular Cholesterol Imbalance. J Cell Biol 5 March 2001; 152 (5): 1057–1070. doi: https://doi.org/10.1083/jcb.152.5.1057
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
